↓ Skip to main content

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

twitter
17 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, March 2019
DOI 10.1002/14651858.cd012930.pub2
Pubmed ID
Authors

Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham, David JW Evans

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 19%
Student > Master 14 15%
Student > Ph. D. Student 9 10%
Researcher 8 9%
Professor 7 8%
Other 22 24%
Unknown 14 15%
Readers by discipline Count As %
Medicine and Dentistry 30 33%
Nursing and Health Professions 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Unspecified 4 4%
Other 17 19%
Unknown 17 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2019.
All research outputs
#1,756,089
of 15,055,678 outputs
Outputs from Cochrane database of systematic reviews
#4,434
of 11,085 outputs
Outputs of similar age
#51,012
of 265,728 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 24 outputs
Altmetric has tracked 15,055,678 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,085 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.